Quantification of Massive Allograft Healing with Dynamic Contrast Enhanced-MRI and Cone Beam-CT: A Pilot Study
- 10 June 2008
- journal article
- research article
- Published by Wolters Kluwer Health in Clinical Orthopaedics and Related Research
- Vol. 466 (8) , 1897-1904
Abstract
Although massive allografts are widely used for reconstruction of critical defects in long bones caused by tumor or trauma, many will have inadequate long-term outcomes. Toward a tissue engineering solution to this problem, we developed experimental stem cell and gene therapy adjuvants that induce angiogenesis, osteogenesis, and remodeling of the structural allografts. We present data from pilot studies to show the utility of dynamic contrast enhanced MRI (DCE-MRI) to quantify vascularity after femoral osteotomy in a canine femur model and cone beam CT (CB-CT) to quantify bone volume in a patient after composite prosthetic-allograft reconstructive surgery. The results demonstrate our ability to suppress the artifacts generated by the metal implants required to secure massive allografts such that precise quantification of cortical bone revascularization (>10-fold increase at 3 weeks postoperatively) and new bone formation (accurate to about 193 μm3) around the graft can be performed longitudinally via DCE-MRI and CB-CT, respectively.Keywords
This publication has 35 references indexed in Scilit:
- Structural Bone Allograft Combined with Genetically Engineered Mesenchymal Stem Cells as a Novel Platform for Bone Tissue EngineeringTissue Engineering, 2007
- Reference tissue quantification of DCE-MRI data without a contrast agent calibrationPhysics in Medicine & Biology, 2007
- Micro-computed tomography prediction of biomechanical strength in murine structural bone graftsJournal of Biomechanics, 2007
- Massive allografts in tumour surgeryInternational Orthopaedics, 2006
- The interobserver-validated relevance of intervertebral spacer materials in MRI artifactingEuropean Spine Journal, 2006
- Salvage of Failed Massive Allograft Reconstruction with EndoprosthesisClinical Orthopaedics and Related Research, 2006
- Biological Effects of rAAV-caAlk2 Coating on Structural Allograft healingMolecular Therapy, 2005
- Randomized Study Evaluating Recombinant Human Bone Morphogenetic Protein‐2 for Extraction Socket AugmentationJournal of Periodontology, 2005
- Use of Recombinant Human Bone Morphogenetic Protein-2 to Achieve Posterolateral Lumbar Spine Fusion in HumansSpine, 2002
- The effect of recombinant human bone morphogenetic protein‐2 on femoral reconstruction with an intercalary allograft in a dog modelJournal of Orthopaedic Research, 2001